2Wilson WA, Gharavi AE, Koike T, at al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum, 1999, 42:1309-1311.
3Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum, 1982, 25: 1271-1277.
4Cervara R, Piette JC, Font J, et al. Antiphospholipid syndrome, clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthritis Rheum, 2002, 46: 1019-1027.
5Munoz-Rodriguez FJ, Front J, Cervera R, et al. Clinical study and follow-up of 100 patients with the antiphospholipid syn- drome. Semin Arthritis Rheum, 1999, 29: 182-190.
6Vianna JL, Khamashta MA, Ordi-Ros J, et al. Comparison of the primary and secondary antiphospholipid syndrome: an European multicenter study of 114 patients. Am J Med, 1994, 96: 3-9.
7Miyakis S, Lockshin MD, Atsumi T, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb I laemost, 2006, 4: 295-306.
8Cervera R, Piette JC, Font J, et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease ex- pression in a cohort of 1 000 patients[ J]. Arthritis Rheum, 2002, 46(4) : 1019 - 1027.
9Tincani A, Bazzani C, Zingarelli S, et al. Lupus and the an- tiphospholipid syndrome in pregnancy and obstetrics : clinical char- acteristics, diagnosis, pathogenesis, and treatment I J]. Semin Thromb Hemost, 2008, 34 (3) : 267 -273.
10Cervera R, Khamashta MA, Shoenfeld Y, et al. Morbidity and mortality in the antiphospholi-pid syndrome during a 5-year period : a multicentre prospective study of 1000 patients [ J ]. Ann Rheum Dis, 2009, 68(9) : 1428 -1432.
